Serum fatty acid synthase and GLP-1 levels in prostate cancer and benign prostatic hyperplasia
This study aimed to investigate the differences in serum fatty acid synthase (FASN) and glucagon-like peptide-1 (GLP-1) levels among patients diagnosed with prostate cancer, benign prostatic hyperplasia (BPH), and healthy controls.
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
De Gruyter
2025-11-01
|
| Ráidu: | Türk Biyokimya Dergisi |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1515/tjb-2025-0254 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|